PGI10 COST-UTILITY ANALYSIS OF USTEKINUMAB VS VEDOLIZUMAB IN CROHN DISEASE IN ITALY
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1133
https://www.valueinhealthjournal.com/article/S1098-3015(19)33511-9/fulltext
Title :
PGI10 COST-UTILITY ANALYSIS OF USTEKINUMAB VS VEDOLIZUMAB IN CROHN DISEASE IN ITALY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33511-9&doi=10.1016/j.jval.2019.09.1133
First page :
Section Title :
Open access? :
No
Section Order :
10990